Skip to content
healthcare.dev

good sense naproxen sodium

NDC 0113-8264, diphenhydramine hydrochloride, naproxen sodium, tablet, film coated, from L. Perrigo Company.

Product NDC
0113-8264
Status
Listed
Labeler
L. Perrigo Company
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA208499
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0113-8264 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIPHENHYDRAMINE HYDROCHLORIDE25 mg/1
  • NAPROXEN SODIUM220 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]

Package NDCNDC-11Package
0113-8264-06001138264061 BOTTLE in 1 CARTON (0113-8264-06) / 160 TABLET, FILM COATED in 1 BOTTLE (0113-8264-00)
0113-8264-60001138264601 BOTTLE in 1 CARTON (0113-8264-60) / 20 TABLET, FILM COATED in 1 BOTTLE
0113-8264-71001138264711 BOTTLE in 1 CARTON (0113-8264-71) / 50 TABLET, FILM COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 0113-8264 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0113-8264 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0113-8264. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.